Cell Therapeutics
Cell Therapeutics "is committed to being a biopharmaceutical-industry leader with a diversified portfolio of proprietary oncology drugs. What makes us different is our personalized approach to cancer therapy that focuses on treating the right patient with the right drug at the right dose." [1]
"Established in September 1991, CTI is headquartered in Seattle, Washington and has a branch office in Bresso (Milan), Italy. There are two CTI subsidiaries: Systems Medicine LLC, Scottsdale, Arizona, guides the development of our oncology products using its systems biology platform; Aequus BioPharma, Inc., a majority owned subsidiary of CTI located in Bainbridge Island, Washington, works to develop and commercialize our Genetic Polymer™ technology." [2]
- James A. Bianco, M.D. Chief Executive Officer
Contents
Directors
Accessed December 2008: [3]
- John H. Bauer Director
- James A. Bianco, M.D. CTI principal founder, CEO, Director
- Vartan Gregorian, Ph.D. Director
- Richard L. Love Director
- Mary O’Neil Mundinger, D.P.H. Director
- Phillip M. Nudelman, Ph.D. Director, Chairman of the Board
- Jack W. Singer, M.D. CTI founder, Chief Medical Officer and Director
- Frederick W. Telling, Ph.D. Director
Contact
Resources and articles
Related Sourcewatch articles
References
- ↑ Corporate Strategy, Cell Therapeutics, accessed December 16, 2008.
- ↑ People and Subsidiaries, Cell Therapeutics, accessed December 16, 2008.
- ↑ Directors, Cell Therapeutics, accessed December 16, 2008.
